Novartis AG (NVSEF)
Novartis Market Cap : 301.49B for Feb. 12, 2026
Market Cap Chart
Historical Data
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
Market Cap Benchmarks
| Roche Holding AG | 374.14B |
| EvoNext Holdings SA | 7.933M |
| Kuros Biosciences Ltd. | 1.254B |
| Basilea Pharmaceutica AG | 871.29M |
Market Cap Related Metrics
| PE Ratio | 22.08 |
| PS Ratio | 5.656 |
| PEG Ratio | 1.010 |
| Price to Book Value | 6.536 |
| Price to Free Cash Flow | 19.47 |
| Price | 158.00 |
| Earnings Yield | 4.53% |
| PEGY Ratio | 0.9063 |
| Operating PE Ratio | 18.15 |
| Normalized PE Ratio | 20.99 |